Alexandria Real Estate Equities, the life science real estate firm headquartered on North Euclid Avenue, has been named one of the Most Charitable Companies in America by Newsweek in the publication’s inaugural ranking announced Tuesday.
The recognition places the S&P 500 company among 300 publicly traded U.S. firms selected for what Newsweek and its research partner Statista described as outstanding corporate philanthropy, employee volunteering, and community investment. Statista evaluated the 2,000 largest publicly traded U.S. companies by revenue, screening them for published corporate social responsibility reports and assessing them through a survey of approximately 18,000 Americans, social media sentiment analysis, and charitable giving metrics, according to a Newsweek announcement.
Alexandria, which trades on the New York Stock Exchange under the ticker ARE, develops and operates laboratory and office campuses in life science research hubs across the country, including Greater Boston, the San Francisco Bay Area, San Diego, and New York City.
The company reported a total market capitalization of $20.75 billion and 35.9 million rentable square feet of operating properties as of December 31, 2025, according to its press release.
Founded in 1994 and based in Pasadena, Alexandria occupies a five-story building at the corner of Euclid Avenue and Union Street, across from Pasadena City Hall.
“We are honored to be recognized as one of America’s Most Charitable Companies by Newsweek,” Joel S. Marcus, executive chairman and founder of Alexandria, said in a company press release.
The designation, Marcus said, “reinforces our steadfast commitment as a mission-driven company to create and grow clusters that advance human health.”
The company described its charitable work as spanning several areas, including accelerating medical research, combating hunger through agricultural technology, supporting military veterans and their families, addressing addiction, promoting education, and prioritizing mental health, according to its press release.
One initiative the company highlighted is its role in a public-private partnership with the Foundation for the National Institutes of Health focused on depression research. Alexandria received the FNIH’s 2025 Charles A. Sanders, MD, Partnership Award in October for its work helping launch the Multi-Level Assessment and Phenotyping in Depression program, known as MAP-D, according to the FNIH. That initiative, developed with the National Institute of Mental Health, the Food and Drug Administration, and the Department of Veterans Affairs, aims to build a precision medicine framework for treating major depressive disorder, according to the company.
The Newsweek recognition follows Alexandria’s inclusion on the publication’s Most Trustworthy Companies in America list for three consecutive years.
“Corporate philanthropy is a reflection of what a company values,” Jennifer H. Cunningham, editor-in-chief of Newsweek, said in a separate announcement of the ranking. Newsweek’s list, she said, highlights businesses that support their communities through investments of “money, time, and talent.”
The full ranking is available at rankings.newsweek.com.
Get our daily Pasadena newspaper in your email box. Free.
Get all the latest Pasadena news, more than 10 fresh stories daily, 7 days a week at 7 a.m.
